Moolec Science (MLEC) EPS (Weighted Average and Diluted) (2022 - 2024)
Moolec Science's (MLEC) quarterly EPS (Weighted Average and Diluted) came in at -$16959.4 in Q4 2024, up 32.33% year-on-year from -$12816.2 in Q1 2024, and down 958814.09% quarter-over-quarter from -$1.77 in Q2 2024.
Moolec Science (MLEC) EPS (Weighted Average and Diluted) (2022 - 2024) Analysis & Trends
Moolec Science has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$16959.4 for Q4 2024.
- EPS (Weighted Average and Diluted) for Q4 2024 came in at -$16959.4, up 32.33% year-over-year; the trailing twelve-month figure through Dec 2024 was -$16959.4 (up 32.33% YoY), and the FY2024 annual result was -$1.77, down 163.78% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$16959.4 for Q4 2024 at Moolec Science, down from -$1.77 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$1.77 in Q2 2024 to a low of -$25061.1 in Q4 2023.
- The 3-year median for EPS (Weighted Average and Diluted) is -$8481.2 (2024), against an average of -$10506.3.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 32.33% in 2024, while the deepest fall reached 32.33% in 2024.
- Moolec Science's EPS (Weighted Average and Diluted) stood at -$3.01 in 2022, then plunged by 833407.76% to -$25061.1 in 2023, then jumped by 32.33% to -$16959.4 in 2024.
- The last three EPS (Weighted Average and Diluted) figures came in at -$16959.4 (Q4 2024), -$1.77 (Q2 2024), and -$25061.1 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -16,959.35 |
| Jun 30, 2024 | -1.77 |
| Dec 31, 2023 | -25,061.08 |
| Jun 30, 2022 | -3.01 |